Trial intelligence / Profile preview

Lubiprostone for Pediatric Functional Constipation

NCT05144295Phase 3Completed

Sponsor
Alexandria University
Start
Jan 2022
Primary completion
Aug 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of cobiprostone in functional constipation (FC) (2 arms), sponsored by Alexandria University. Started Jan 2022; status: completed.

02

Drugs

cobiprostone
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on NCT05144295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05144295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call